Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: JAMA Neurol. 2013 Jul;70(7):883–890. doi: 10.1001/jamaneurol.2013.1425

Figure 4.

Figure 4

Mean (SE) baseline to week 20 change in the ratio of myo-inositol (MI) to creatine plus phosphocreatine (Cr) by treatment group (placebo vs growth hormone–releasing hormone [GHRH]), expressed as residualized change scores. WM indicates white matter. *P <.05.